Cargando…

Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study

BACKGROUND: The phenotypic stability of mixed connective tissue disease (MCTD) is not clear, and knowledge about disease activity and remission is scarce. We aimed to establish the occurrence of evolution from MCTD to another defined rheumatic condition, and the prevalence and durability of remissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiseter, Silje, Gunnarsson, Ragnar, Corander, Jukka, Haydon, Joanna, Lund, May Brit, Aaløkken, Trond Mogens, Taraldsrud, Eli, Hetlevik, Siri Opsahl, Molberg, Øyvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740892/
https://www.ncbi.nlm.nih.gov/pubmed/29268795
http://dx.doi.org/10.1186/s13075-017-1494-7
_version_ 1783288101481742336
author Reiseter, Silje
Gunnarsson, Ragnar
Corander, Jukka
Haydon, Joanna
Lund, May Brit
Aaløkken, Trond Mogens
Taraldsrud, Eli
Hetlevik, Siri Opsahl
Molberg, Øyvind
author_facet Reiseter, Silje
Gunnarsson, Ragnar
Corander, Jukka
Haydon, Joanna
Lund, May Brit
Aaløkken, Trond Mogens
Taraldsrud, Eli
Hetlevik, Siri Opsahl
Molberg, Øyvind
author_sort Reiseter, Silje
collection PubMed
description BACKGROUND: The phenotypic stability of mixed connective tissue disease (MCTD) is not clear, and knowledge about disease activity and remission is scarce. We aimed to establish the occurrence of evolution from MCTD to another defined rheumatic condition, and the prevalence and durability of remission after long-term observation. METHODS: In this large population-based prospective observational MCTD cohort study (N = 118), disease conversion was defined by the development of new auto-antibodies and clinical features compliant with another well-defined rheumatic condition. Remission was defined by a combination of systemic lupus erythematosus disease activity index 2000 (SLEDAI-2 K) of 0 and European League Against Rheumatism scleroderma trials and research (EUSTAR) activity index <2.5. Predictors of phenotypic stability and disease remission were assessed by logistic regression. RESULTS: Among 118 patients, 14 (12%) developed another well-defined rheumatic condition other than MCTD after mean disease duration of 17 (SD 9) years. Puffy hands predicted a stable MCTD phenotype in univariable regression analysis (OR 7, CI 2–27, P = .010). Disease activity defined by SLEDAI-2 K, decreased gradually across the observation period and > 90% of patients had EUSTAR activity index <2.5. There were 13% patients in remission throughout the whole mean observation period of 7 (SD 2) years. The strongest predictor of remission was percentage of predicted higher forced vital capacity. CONCLUSIONS: Our results strengthen the view of MCTD as a relatively stable disease entity. Long-term remission in MCTD is not frequent; however, the low SLEDAI-2 K and EUSTAR scores during the observation period suggests that the disease runs a milder course than systemic lupus erythematosus and systemic sclerosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1494-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5740892
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57408922018-01-03 Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study Reiseter, Silje Gunnarsson, Ragnar Corander, Jukka Haydon, Joanna Lund, May Brit Aaløkken, Trond Mogens Taraldsrud, Eli Hetlevik, Siri Opsahl Molberg, Øyvind Arthritis Res Ther Research Article BACKGROUND: The phenotypic stability of mixed connective tissue disease (MCTD) is not clear, and knowledge about disease activity and remission is scarce. We aimed to establish the occurrence of evolution from MCTD to another defined rheumatic condition, and the prevalence and durability of remission after long-term observation. METHODS: In this large population-based prospective observational MCTD cohort study (N = 118), disease conversion was defined by the development of new auto-antibodies and clinical features compliant with another well-defined rheumatic condition. Remission was defined by a combination of systemic lupus erythematosus disease activity index 2000 (SLEDAI-2 K) of 0 and European League Against Rheumatism scleroderma trials and research (EUSTAR) activity index <2.5. Predictors of phenotypic stability and disease remission were assessed by logistic regression. RESULTS: Among 118 patients, 14 (12%) developed another well-defined rheumatic condition other than MCTD after mean disease duration of 17 (SD 9) years. Puffy hands predicted a stable MCTD phenotype in univariable regression analysis (OR 7, CI 2–27, P = .010). Disease activity defined by SLEDAI-2 K, decreased gradually across the observation period and > 90% of patients had EUSTAR activity index <2.5. There were 13% patients in remission throughout the whole mean observation period of 7 (SD 2) years. The strongest predictor of remission was percentage of predicted higher forced vital capacity. CONCLUSIONS: Our results strengthen the view of MCTD as a relatively stable disease entity. Long-term remission in MCTD is not frequent; however, the low SLEDAI-2 K and EUSTAR scores during the observation period suggests that the disease runs a milder course than systemic lupus erythematosus and systemic sclerosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1494-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-21 2017 /pmc/articles/PMC5740892/ /pubmed/29268795 http://dx.doi.org/10.1186/s13075-017-1494-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Reiseter, Silje
Gunnarsson, Ragnar
Corander, Jukka
Haydon, Joanna
Lund, May Brit
Aaløkken, Trond Mogens
Taraldsrud, Eli
Hetlevik, Siri Opsahl
Molberg, Øyvind
Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
title Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
title_full Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
title_fullStr Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
title_full_unstemmed Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
title_short Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
title_sort disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740892/
https://www.ncbi.nlm.nih.gov/pubmed/29268795
http://dx.doi.org/10.1186/s13075-017-1494-7
work_keys_str_mv AT reisetersilje diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy
AT gunnarssonragnar diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy
AT coranderjukka diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy
AT haydonjoanna diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy
AT lundmaybrit diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy
AT aaløkkentrondmogens diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy
AT taraldsrudeli diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy
AT hetleviksiriopsahl diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy
AT molbergøyvind diseaseevolutioninmixedconnectivetissuediseaseresultsfromalongtermnationwideprospectivecohortstudy